Jason D. Sadler - 22 Feb 2023 Form 4 Insider Report for Cigna Group (CI)

Role
Pres., International Health
Signature
Kevin Ciaglo, attorney-in-fact
Issuer symbol
CI
Transactions as of
22 Feb 2023
Transactions value $
$0
Form type
4
Filing time
24 Feb 2023, 20:13:19 UTC
Previous filing
12 Dec 2022
Next filing
28 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +1.69K +4.21% $0.00 41.9K 22 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Award $0 +6.26K $0.00 6.26K 22 Feb 2023 Common Stock, $.01 Par Value 6.26K $294.61 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units vest in three equal annual installments beginning March 1, 2024.
F2 This option vests in three equal annual installments beginning March 1, 2024.